Gaishi Long (盖世龙)盖世龙
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字J20110005
生产企业Manufacturer
- 日本新药株式会社小田原综合制剂工厂Riben Xinyao Zhushi Huishe Xiaotian Yuanzong Hezhi Jigong Chang
主要成分Active Ingredients
- 其化学名为Qihua Xueming Wei
- 二氨基Eran Ji
- 二氯苯基Erlv Benji
- 三嗪顺丁烯二酸盐Sanqin Shunding Xier Suanyan
药物知识说明
国药准字J20110005是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括:三嗪顺丁烯二酸盐Sanqin Shunding Xier Suanyan、二氨基Eran Ji、二氯苯基Erlv Benji、其化学名为。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品:三嗪顺丁烯二酸盐-30e98752成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盖世龙) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 三嗪顺丁烯二酸盐Sanqin Shunding Xier Suanyan, 二氨基Eran Ji, 二氯苯基Erlv Benji.
Explore other medicines containing the same ingredient: 三嗪顺丁烯二酸盐 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盖世龙Recorded Chinese name: 盖世龙
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 2mg2 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 日本新药株式会社小田原综合制剂工厂Riben Xinyao Zhushi Huishe Xiaotian Yuanzong Hezhi Jigong Chang
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字J20110005
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字J20110005
Manufacturer
Chinese legal name: 日本新药株式会社小田原综合制剂工厂
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字J20110005
生产企业
日本新药株式会社小田原综合制剂工厂
适应症
本品治疗胃溃疡。
用法用量
口服,一日4mg,分1~2次服。随年龄、症状适当增减计剂量。
不良反应
偶有头晕、恶心、呕吐、便秘、腹泻、皮疹、食欲减退、上腹部不适,偶见氨基转移酶轻度可逆性升高。
禁忌
小部分经肾由尿中排泄,因此肾功能不全者慎用。
注意事项
1.出现皮疹不良反应时,应停药。
2.老年患者应从小剂量(2mg/日)开始,根据反应情况适当调整剂量。
贮藏
密闭,干燥处保存。
规格
2mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.